Addex Pharmaceuticals CEO Steps Down

Addex Shareholders Appoint Hoyoung Huh and Oleg Nodelman to Board, Approve All Board Proposals at Annual General Meeting

Addex Initiates Phase IIa Clinical Trial of Dipraglurant-IR in Parkinson’s Disease Levodopa-Induced Dyskinesia (PD-LID)

Addex Partner Starting Clinical Schizophrenia Trial

Addex Converts Mandatory Convertible Notes and Issues Ordinary Shares

Addex Board Proposes Hoyoung Huh and Oleg Nodelman for Election to the Board of Directors

Addex Pharmaceuticals 2010 Financial Results

Addex Pharmaceuticals 2010 Financial Results Next Wednesday

Addex Awarded EuropaBio’s Most Innovative SME Award

Addex Highlights Strength of Allosteric Modulation Technology Platform with Multiple Presentations at Society for Neuroscience 2010